RECOGNITION

  • Vitamin deficiency usually develops slowly over several months to years
  • Vitamin deficiency signs and symptoms may be subtle at first
    • increase as the deficiency worsens

Symptoms

Neurological

  • Numbness or paraesthesia
  • Muscle weakness
  • Unsteady movements

Megaloblastic anaemia

  • Breathlessness
  • Fatigue
  • Dizziness

Non-specific

  • Memory loss
  • Personality changes
  • Mental confusion or forgetfulness
  • Irregular heartbeats

Signs

  • Pale or yellowish skin
  • Glossitis
  • Peripheral neuropathy
    • especially proprioception
    • Sub-acute combined degeneration of the cord
    • which may occur in the absence of anaemia

Assessment

  • Diet
  • Features of malabsorption
  • Personal/FH of autoimmune conditions
  • GI surgery
  • Medication use
    • e.g. proton pump inhibitors, metformin, OCP
  • Pregnancy and OCP
    • oestrogen reduces serum B12 (but not functional B12)
    • by 25% on oral contraceptive pill
    • by <30% by third trimester of pregnancy
    • level >150 pg/mL may therefore be normal

Investigations

  • FBC
  • Folate
  • Serum cobalamin (B12)
  • Anti-intrinsic factor Ab (anti-IF Ab)
    • if suspect PA, test for anti-IFAB regardless of cobalamin levels

INITIAL MANAGEMENT

Symptoms/signs of B12 deficiency present

Management of low serum cobalamin (B12) levels where symptoms/signs of B12 deficiency present

flowchart-1

B12  low but symptoms/signs absent

  • B12 ≤ 200 pg/mL
  • Non-specific symptoms
Management of low serum cobalamin (B12) levels in the absence of objective clinical parameters

flowchart-2

TREATMENT

Pernicious anaemia

  • Prescribe vitamin B12 as hydroxocobalamin
  • Treatment regimens are dependent on symptoms/signs. See BNF

Dietary cause

  • Dietary sources of B12 include eggs, milk/dairy products, salmon, fortified products e.g. cereals
  • In the absence of neuropathy, consider oral cyanocobalamin 50–250 microgram daily taken between meals (although higher doses <2000 mg may be required)
    • check B12 levels at 1–3 months
  • Duration of B12 supplementation depends on the cause of the deficiency and response
  • When using oral cyanocobalamin, caution regarding possible emerging pernicious anaemia

RBC transfusion in chronic anaemia 

  • Consider a single unit RBC transfusion in patients with:
    • moderate/severe symptoms
    • haemodynamically stable
    • reversible cause of anaemia
    • Hb <90 g/L
  • Remember each unit transfused is a treatment decision
  • See Chronic Anaemia: RBC transfusion

ASSESSING RESPONSE

  • If patient receiving IM hydroxocobalamin, do not routinely check B12 levels
  • Monitor for hypokalaemia after commencing B12 replacement and consider replacement
  • If PA, assess reticulocyte response at 7–10 days
    • suboptimal response may indicate concomitant iron deficiency

DISCHARGE

  • Inform GP of:
    • cause
    • treatment
    • monitoring required

© 2022 The Bedside Clinical Guidelines Partnership.

Created by University Hospital North Midlands and Keele University School of Computing and Mathematics.

Research and development team: James Mitchell, Ed de Quincey, Charles Pantin, Naveed Mustfa